SINGAPORE, Jan. 22, 2025 /PRNewswire/ — PCX Markets, a marketplace for audited, traceable plastic waste recovery and responsible processing, today announced that it has been certified as a B Corporation™ (B Corp™), further recognizing the company’s commitment to environmental and social responsibility.

B Corp is a global movement of over 9,400 pioneering companies across 105 countries that use business as a force for good, and includes trailblazers like Ben & Jerry’s, Patagonia, Allbirds, and Coursera.

To become a B Corp company, PCX Markets underwent a rigorous assessment of every part of the business against five key impact areas: governance, workers, community, environment, and customers. Achieving B Corp Certification by the non-profit B Lab reaffirms PCX Market’s deep commitment to transparency and accountability.

“The team at PCX is on mission to accelerate the transition to a circular economy, and build a future where no plastic waste ends up in nature. We are proud to have achieved B Corp certification, and incredibly excited to join this global movement of purpose-driven businesses,” said Sebastian DiGrande, PCX Markets CEO. 

The world has produced about 9 billion metric tons of plastic since the 1950s. Today, only 9% of plastic waste is recycled, 19% incinerated, and 72% is either landfilled, dumped, openly burned or ends up in the environment. Even if we were to reduce production from today’s levels by 40% by 2050, the world would still produce another 11 billion tons that needs to be responsibly managed.

PCX Markets activates an ecosystem of partners who collect, transport and responsibly process plastic waste, while supporting the communities most impacted by the global plastic waste crisis with programs that improve livelihoods and scale social impact. Companies that want to complement upstream reduction efforts by funding downstream plastic waste recovery can purchase credits issued by projects battling plastic pollution. One credit cleans up one metric ton of plastic pollution. The impact is delivered immediately and verified by a third-party auditor.

PCX Markets, which is headquartered in Singapore, has enabled the clean up of over 108 million kilograms of plastic waste worldwide to date.

“As a B Corp in the sustainability sector, we’re thrilled to be counted among businesses that are building an inclusive, equitable, and regenerative economy,” said Nanette Medved-Po, Founder of PCX Markets.

ABOUT PCX

PCX is on a mission to accelerate the transition to a circular economy and build a future where no plastic ends up in nature. 

PCX Markets is a fully transparent plastic credit marketplace for audited, traceable plastic waste recovery and responsible processing worldwide. Our marketplace activates an ecosystem of partners who collect, transport and responsibly process plastic waste, while supporting communities on the ground with programs that improve livelihoods and scale social impact. PCX Markets, which is headquartered in Singapore, has enabled the clean up of over 108  million kilograms of plastic waste worldwide.

About B Lab

B Lab is transforming the global economy to benefit all people, communities and the planet. A leader in economic systems change, our global network creates standards, policies, tools, and programs for business, and we certify companies – known as B Corps – who are leading the way. To date, our community includes over 900,000 workers in over 9,400 B Corps across 105 countries and 160 industries. The B Impact Assessment is used by more than 150,000 companies to help measure, manage and improve their impact. To learn more and join the movement, visit www.bcorporation.net.

About Certified B Corporations™

Certified B Corporations, or B Corps™, are companies verified by B Lab to meet the high standards of social and environmental performance, transparency and accountability.

For press enquiries, contact marketing@pcxmarkets.com

SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ — Hyundai ADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug OTX-M, developed from the well-known injectable chemotherapy drug docetaxel, at the “Biotech Showcase 2025” held in San Francisco from January 13 to 15. The company introduced a “new paradigm in cancer treatment,” shifting from intravenous chemotherapy to patient-centered oral chemotherapy.

Technological Innovation: OTX-M Based on Organic-Inorganic Hybrid Drug Delivery Technology

OTX-M was developed using the patented organic-inorganic hybrid oral drug delivery technology of Hyundai ADM’s affiliated company, CNPharm. Unlike other oral anti-cancer drugs that failed to address drug-drug interaction issues, OTX-M enhances the bioavailability of docetaxel by more than 1,600 times without relying on metabolic inhibitors such as P-gp inhibitors or ritonavir. This breakthrough effectively resolves the challenge of low bioavailability while eliminating concerns about drug interactions.

Preclinical Study Results Identify the Optimal Regimen as One Daily Dose at a Moderate Dosage

The preclinical study systematically evaluated the effects of varying dosages (low, moderate, and high) and dosing frequencies, assessing anti-tumor efficacy and safety, as measured by weight changes.

Low doses administered twice daily showed a tumor inhibition rate of 61.4%, with minimal side effects and stable weight maintenance.

Moderate doses administered once daily achieved a tumor inhibition rate of 82.83%, demonstrating the best balance between anti-tumor efficacy and weight stability.

High doses administered four times per week achieved the highest tumor inhibition rate of 92.81%. However, weight loss and increased risk of side effects made this approach unsuitable for long-term cancer treatment.

The study demonstrated the dose-dependent anti-tumor efficacy of OTX-M, highlighting its excellent safety profile and low risk of side effects. A comprehensive analysis determined that a once-daily moderate dosage offers the optimal balance between efficacy and safety.

The Potential of OTX-M in the Global Cancer Treatment Market

OTX-M is expected to provide greater patient convenience and economic advantages, with the potential to rapidly replacing the current market dominated by injectable chemotherapy drugs. Research by Rutgers University and Chung-Ang University suggests that oral anti-cancer therapies can reduce treatment costs by 59.9% compared to injectable chemotherapies. This cost-effectiveness makes them an ideal solution for underdeveloped regions with limited medical resources. Additionally, the ability for patients to self-administer the medication at home, without the need for hospital visits, provides significant benefits for both patients and healthcare systems.

Global Industry Experts Highlight OTX-M’s Paradigm-Shifting Potential

A lead researcher from the new drug development division of a global pharmaceutical company, attending the Biotech Showcase commented, “The transition of taxane-based drugs, such as docetaxel and paclitaxel, into oral formulations has been a long-standing challenge that many pharmaceutical companies have attempted but failed to overcome. OTX-M represents the first example of successfully addressing both bioavailability and safety concerns. This technology could be a game-changer for cancer treatment and is expected to establish itself as an oral anti-cancer therapy in the global market following clinical trials in the United States.”

Hyundai ADM’s Commitment to Innovation in Cancer Treatment

Hyundai ADM’s CEO, Taek-Sung Kim, stated, “OTX-M is an innovative treatment that converts intravenous chemotherapy drugs into oral therapies with lowered side effects, significantly improving patient convenience and quality of life. We aim to usher in an era where cancer can be managed as a chronic condition, like diabetes or hypertension, and play a leading role in the global anti-cancer market.”

About Hyundai ADM Bio and Hyundai Bioscience

Hyundai ADM Bio is a subsidiary of Hyundai Bioscience, is a biotechnology company that develops anticancer drugs and also a Clinical Research Organization (CRO) service company in South Korea. ADM Korea Inc. is listed on the KOSDAQ market (symbol: 187660).

Hyundai Bioscience is a biotechnology company that develops new drugs based on its novel drug delivery system technologies to deliver active ingredients safely and efficiently to targeted areas of the human body. Founded in 2000, Hyundai Bioscience focuses on repurposing or expanding indications of existing drugs using its proprietary organic-inorganic hybrid technologies. Hyundai Bioscience is a public company listed on KOSDAQ (symbol: 048410) in South Korea.

– Delivers Authentic Listening Experience by Expressing Three Elements of Spatial Reverberation, Quietness, and Dynamic Range While Preserving Natural “Texture” of Musical Instruments –

KYOTO, Japan, Jan. 22, 2025 /PRNewswire/ — ROHM has developed a 32-bit D/A converter IC (DAC chip) and an evaluation board for flagship models in its MUS-IC (TM) series, optimized for high-resolution audio playback. DAC chips are key to audio equipment quality. With over 50 years of expertise, ROHM ensures superior sound design through high-fidelity processors and premium audio power ICs.

Product video: https://youtu.be/5VnsX4SSRQY?si=t_n5OzxBmLpliYZb

ROHM’s latest product builds upon the first-generation MUS-IC (TM) BD34301EKV, renowned for its sound quality and adoption in high-end models. The BD34302EKV inherits the core design concept behind ROHM’s DAC chip, which emphasizes natural flat sound. By integrating the three elements of spatial reverberation, quietness, and dynamic range from the MUS-IC (TM) series, it authentically reproduces the “texture” of musical instruments for an even more realistic audio experience.

Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202501092652/_prw_PI1fl_39cYfY1W.jpg

By incorporating a new algorithm for data-weighted averaging (DWA), the BD34302EKV achieves a THD+N characteristic of -117dB (THD: -127dB), a key performance indicator that enhances sound quality by achieving a sound quality that conveys a realistic sense of texture. In addition, the signal-to-noise ratio (SNR) of 130dB provides noise performance befitting a flagship DAC chip, while a sampling frequency of up to 1,536kHz allows customers to fully leverage the high-precision calculations of their digital signal processors (DSPs).

Product image: https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202501092652/_prw_PI4fl_vtl1N22C.jpg

In monaural mode, which allocates one DAC chip per channel, ROHM’s proprietary HD (high definition) monaural mode contributes to smoother, more natural sound. As part of the MUS-IC (TM) series, uncompromising craftsmanship has been applied down to the smallest details. Based on years of expertise in sound quality design, the optimal bonding wire material for each terminal of the BD34302EKV was selected to accurately convey the natural “texture” of musical instruments. These features help create the ideal sound sought by high-end audio manufacturers.

Special page: https://micro.rohm.com/en/mus-ic/

*In this release, “DAC chip” differentiates the IC from the DAC in audio equipment.

*MUS-IC is a trademark or registered trademark of ROHM Co., Ltd.

Release: https://www.rohm.com/news-detail?news-title=2025-01-22_news_music&defaultGroupId=false

About ROHM: https://kyodonewsprwire.jp/attach/202501092652-O1-39CK07wm.pdf

Logo: https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202501092652/_prw_PI3fl_o748borj.jpg

Official website: https://www.rohm.com/

DAVOS, Switzerland, Jan. 22, 2025 /PRNewswire/ — Automation Anywhere Inc.(AAI), the world’s leading Agentic Process Automation (APA) platform, and PwC India strengthened their partnership by integrating advanced Agentic AI capabilities from Automation Anywhere into PwC India’s proprietary Intelligent Spend Management Suite (ISMS).

PwC India’s Intelligent Spend Management Suite (ISMS) is an Agentic AI platform designed to transform the way businesses manage their spend and run their payable operations. This product leverages the power of  Generative AI agents which will now be powered by Automation Anywhere. This will give ISMS specific capabilities to drive intelligent buying decisions, execute touchless account payables and enhance critical outcomes.

This modular, Agentic AI platform allows API integrations with existing systems to greatly improve operational efficiency, transparency and insights for better decisions. 

In 2024, Automation Anywhere announced a strategic partnership with PwC India to develop Generative AI-driven solutions aimed at transforming key business operations. The integration of Automation Anywhere’s advanced Agentic AI capabilities into PwC India’s Intelligent Spend Management Suite (ISMS) marks a significant milestone in the collaboration.  

Commenting on the announcement with Automation Anywhere, Sanjeev Krishan, Chairperson, PwC in India said, “The integration of Automation Anywhere’s advanced Agentic AI capabilities into PwC India’s Intelligent Spend Management Suite represents a step forward in addressing some of the most pressing challenges faced by businesses today. By combining our deep industry insights, AI & Tech expertise and domain understanding with Automation Anywhere’s Agentic AI platform, we are empowering organizations across sectors to drive efficiency, enhance decision-making, and unlock greater value in their spend and payable operations.”

Joe Atkinson, PwC’s Global Chief AI Officer added, “Agentic AI is a step-change in the AI revolution, one that is going to play a significant role in the business model reinvention of enterprises globally. AI is starting to disrupt value chains across whole industries, and with ISMS value realization for businesses becomes real. I’m excited to see the collaboration between us and Automation Anywhere.”

“Our industry-leading Agentic Process Automation platform has the unparalleled ability to drive actions by solving real world customer problems with GenAI. We recognize PwC India’s market potential that will significantly increase the deployment of AI Agents aiding in a strategic long-term vision to deliver superior business outcomes for our customers,” said Ankur Kothari, Chief Operating Officer, Automation Anywhere.

Manpreet Singh Ahuja, Chief Digital Officer and Partner, PwC India said, “PwC India’s Intelligent Spend Management Suite which leverages Agentic AI, is an example of our commitment to move AI from experimentation to enterprise grade deployments. This product addresses a key business challenge: making payables management smarter and more efficient. Working with Automation anywhere, we will be able bring collective expertise of both enterprises to solve client challenges.”

Key features of PwC India’s Intelligent Spend Management Suite (ISMS) include:

• Generative AI agents for advanced process insights, validation and executing actions
• Modular design for seamless integration with existing systems
• API-first architecture for faster implementation and scalability
• Strong underlying layer of data, validations, and workflow implementations

The combined efforts of Automation Anywhere with PwC India is poised to develop breakthrough solutions that will revolutionize the way of working across several business verticals.

About Automation Anywhere Inc

Automation Anywhere is the world’s leading Agentic Process Automation (APA) Platform that puts AI to work across organizations. The company’s platform is powered with specialized AI, generative AI and offers process discovery, RPA, AI agents, end-to-end process orchestration, document processing and analytics, with a security and governance-first approach. Automation Anywhere empowers organizations worldwide to unleash productivity gains, improve customer experiences and create new revenue streams. The company is guided by its vision to fuel the future of work by unleashing human potential through Agentic AI-powered automation. Learn more at www.automationanywhere.com

About PwC

At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 152 countries with over 327,000 people who are committed to delivering quality in Assurance, Advisory and Tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.

PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

DUBAI, UAE , Jan. 21, 2025 /PRNewswire/ — Anbio Biotechnology (“Anbio”), a global leader in in-vitro diagnostic technologies, is excited to announce its participation in the 2025 Medlab Middle East exhibition, taking place from 3rd to 6th February at the Dubai World Trade Centre. The event is one of the region’s largest and most important medical and laboratory equipment trade shows, bringing together leading manufacturers, distributors, and healthcare professionals from around the globe.

Anbio Biotechnology will be showcasing a range of its latest Point-of-Care Testing (POCT) products at Booth Z1.H50. These products include:

• Dry Chemiluminescence Immunoassay System (Dry CLIA)
• Immunofluorescence System (FIA)
• Dry Biochemistry System
• Colloidal Gold Rapid Tests

The company’s participation aims to provide healthcare professionals, medical device distributors, and patients in the Middle East, Africa, and Europe with fast, reliable, and cost-effective in-vitro diagnostic solutions that enhance healthcare outcomes.

Anbio’s Featured Products at Medlab Middle East:

• Dry Chemiluminescence Immunoassay System

The innovative dry chemiluminescence immunoassay system utilizes lyophilized reagents to enhance stability, reduce liquid reagent volume, and improve temperature resistance for room-temperature storage and transport. Compatible with nearly 70 reagents, it covers applications like coagulation, thrombosis, cancer markers, and hormone testing, ensuring reliable results across various clinical settings.

• Immunofluorescence System

Ideal for rapid and precise detection, this immunofluorescence system is a powerful tool for Point-of-Care Testing (POCT). It supports 85 test parameters and is equipped with a built-in battery, allowing up to 8 hours of continuous testing without an external power source. Its versatility makes it suitable for various environments, including laboratories, ambulances, and pharmacies, ensuring reliable diagnostics wherever needed.

• Dry Biochemistry System

The innovative dry biochemistry system ensures simplicity, efficiency, and reliability in various tests, particularly in emergency settings. It utilizes dry reagent strips, with one strip dedicated to each patient, and supports whole blood testing for most assays. The reagents can be stored and transported at room temperature. Offering quick and accurate biochemistry quantification, results are available in as little as 40 seconds, making it the ideal solution for fast-paced environments.

• Colloidal Gold Rapid Tests

These tests provide a quick, easy-to-read, and reliable solution for detecting a variety of infections and conditions, offering fast results for better decision-making in patient care. With a wide range of available reagents, the system covers nearly 100 different test items, making it a cost-effective choice, particularly for large-scale screening.

About Medlab Middle East

Medlab Middle East is the region’s premier event for laboratory and medical professionals, providing access to a vast array of the latest innovations in diagnostics, laboratory management, and medical technology. With thousands of visitors and exhibitors from around the world, it serves as a vital platform for networking, collaboration, and learning about emerging trends in healthcare diagnostics.

Anbio Biotechnology’s innovative solutions at Medlab Middle East will demonstrate its commitment to advancing the future of diagnostic technology and improving healthcare delivery worldwide.

Visit us at Booth Z1.H50 at Medlab Middle East to learn more about our products and how they can transform your healthcare practices.

• Corporate Knights acknowledges LG Energy Solution in the World’s 100 Most Sustainable Corporations 2025 list, placing it in the top position among its industry peer group
• Recognition in sustainable revenue and sustainable investment were the main drivers of the strong performance, as well as energy productivity and GHG (Greenhouse gas) productivity
• Embracing responsibility as an industry leader, LG Energy Solution strives to bolster its own ESG management and pave the way to a sustainable battery ecosystem across the entire value chain, including indirect operations and suppliers

SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ — LG Energy Solution has ranked 12th on the list of 100 Most Sustainable Corporations in the World 2025 by Corporate Knights, marking its debut on the prestigious list. The company also secured the top position among its battery manufacturing peers.

Corporate Knights’ Global 100 is a global sustainability index that provides an annual ranking of the world’s most sustainable corporations with annual revenues of over 1 billion USD. This year’s evaluation examined 8,359 corporations, scoring companies based on 25 key performance indicators across areas such as sustainable revenue, sustainable investment, resource management, employee management, financial management, and supplier performance. A ranking on this list is widely considered a mark of distinction for ESG management excellence.

LG Energy Solution’s strong performance in the sustainable revenue and sustainable investment KPIs earned its recognition in the Global 100 assessment, meeting key criteria for ESG-conscious investors. The company received the highest possible scores in both areas, reflecting its core business of providing sustainable and reliable energy solutions and its significant investments in future growth engines.

Corporate Knights also highly rated LG Energy Solution’s energy productivity and GHG productivity, among other criteria.

LG Energy Solution is dedicated to strengthening its ESG standards and practices, demonstrating the company’s industry leadership. As such, the company has recently focused on preparations for stricter global regulations and ESG disclosure standards. Even before new international battery regulations, such as mandatory carbon footprint disclosure and battery passports, LG Energy Solution already adopted Life Cycle Assessment (LCA) in 2019 to evaluate the product impacts and transparently communicate with key stakeholders. LG Energy Solution aims to ensure the accuracy and credibility of LCA through third-party verification and Environmental Product Declaration (EPD) certifications, and the range of products covered by LCA and EPD continues to expand. In 2024, LCA covered battery cells with 83% of total capacity, and EPD certified battery cells with 60% of total capacity.

Furthermore, the company made substantial progress in social footprint management, reducing the potential for adverse human rights impacts by adopting a due diligence process to identify, prevent, mitigate, and address such issues. Enhancing its ESG governance, LG Energy Solution is committed to effectively managing emerging challenges and fostering an ESG-driven work culture.

In addition to reinforcing its own ESG management, the company is working to facilitate a sustainable battery ecosystem throughout its entire value chain by proactively supporting, engaging, and collaborating with its supply chain partners. Building on years of assessing and managing ESG risks in its Tier 1 suppliers, the company expanded these efforts in 2024, developing an IT management system that connects Tier-N suppliers for improved traceability and transparency. It plans to progressively broaden the scope of supply chain risk assessment, focusing on core raw material supply chains for critical regulatory compliance. To maintain transparency, LG Energy Solution published the ‘Supply Chain Sustainability Report’ this month, which provides information on its supply chain management system, strategies, and key achievements.

“We are honored that Corporate Knights has recognized our leadership in sustainability and ESG practices, naming us one of the world’s most sustainable companies,” said David Kim, CEO of LG Energy Solution. “We are fully committed to realizing our vision of leading the future green energy era with innovation in electrification for a sustainable battery ecosystem.”

“As one of the world’s largest battery manufacturers, LG Energy Solution is at the centre of what enables the transition to a net-zero economy. The company’s inclusion in the 2025 Global 100 is a testament to its global leadership,” said Toby Heaps, CEO of Corporate Knights.

About LG Energy Solution

LG Energy Solution (KRX: 373220), a split-off from LG Chem, is a leading global manufacturer of lithium-ion batteries for electric vehicles, mobility, IT, and energy storage systems. With 30 years of experience in revolutionary battery technology and extensive research and development (R&D), the company is the top battery-related patent holder in the world with over 58,000 patents. Its robust global network, which spans North America, Europe, and Asia, includes battery manufacturing facilities established through joint ventures with major automakers. Committed to building sustainable battery ecosystem, LG Energy Solution aims to achieve carbon neutrality across its value chain by 2050, while embodying the value of shared growth and promoting diverse and inclusive corporate culture. To learn more about LG Energy Solution’s ideas and innovations, visit https://news.lgensol.com.